Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Siemens Healthineers AGLTS:0PMJ -3.61%79 Return-on-Tangible-Equity is Negative Tangible Equity% as of Mar. 2026. GuruFocus rates LTS:0PMJ with a GF Score™ of 79/100 and a GF Value™ of €52.27 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 759 Medical Devices & Instruments companies, Siemens Healthineers AG ranks better than 99.87% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Siemens Healthineers AG's annualized net income for the quarter that ended in Mar. 2026 was €2,024 Mil. Siemens Healthineers AG's average shareholder tangible equity for the quarter that ended in Mar. 2026 was €-5,351 Mil. Therefore, Siemens Healthineers AG's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was Negative Tangible Equity%.
The historical rank and industry rank for Siemens Healthineers AG's Return-on-Tangible-Equity or its related term are showing as below:
LTS:0PMJ'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 245.18 Med: 245.18 Max: 245.18
Current: Negative Tangible Equity
During the past 11 years, Siemens Healthineers AG's highest Return-on-Tangible-Equity was 245.18%. The lowest was 245.18%. And the median was 245.18%.
LTS:0PMJ's Return-on-Tangible-Equity is ranked better than 99.87% of 759
companies
in the Medical Devices & Instruments industry
Industry Median: 4.04
vs LTS:0PMJ: Negative Tangible Equity
Siemens Healthineers AG (LTS:0PMJ) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Siemens Healthineers AG Return-on-Tangible-Equity Related Terms
Siemens Healthineers AG Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Siemens Healthineers AG's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Siemens Healthineers AG Return-on-Tangible-Equity Chart
LTS:0PMJ vs ABT, SYK, MDT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, Siemens Healthineers AG's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Siemens Healthineers AG Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Siemens Healthineers AG's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of Negative Tangible Equity% mean?
Siemens Healthineers AG (LTS:0PMJ) has a Return-on-Tangible-Equity of Negative Tangible Equity% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Siemens Healthineers AG and its competitors. Over the past decade, Siemens Healthineers AG's Return-on-Tangible-Equity has ranged from 245.18 to 245.18. According to the industry distribution chart, Siemens Healthineers AG ranks #1 out of 759 companies in the Medical Devices & Instruments industry, placing it in the top 0.099999999999994%.
Is Siemens Healthineers AG's Return-on-Tangible-Equity too high?
Siemens Healthineers AG's current Return-on-Tangible-Equity is Negative Tangible Equity%. Over the past 10 years, this metric has ranged from a low of 245.18 to a high of 245.18. Based on the distribution chart, Siemens Healthineers AG ranks #1 out of 759 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Siemens Healthineers AG has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Siemens Healthineers AG's Return-on-Tangible-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Siemens Healthineers AG ranks #1 out of 759 companies for Return-on-Tangible-Equity. This places Siemens Healthineers AG in the top 0% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 4.04. Historically, Siemens Healthineers AG's own Return-on-Tangible-Equity has ranged from 245.18 to 245.18 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.04, based on 759 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Siemens Healthineers AG and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Siemens Healthineers AG's current Return-on-Tangible-Equity is Negative Tangible Equity%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siemens Healthineers AG stock overvalued right now?
Based on GuruFocus' analysis, Siemens Healthineers AG (LTS:0PMJ) is currently considered Possible Value Trap. The stock's GF Value™ is €52.27, compared to a current price of €34.31 — trading 34.4% below its estimated fair value. The current Return-on-Tangible-Equity is Negative Tangible Equity%. Siemens Healthineers AG's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Siemens Healthineers AG (LTS:0PMJ), the current Return-on-Tangible-Equity is Negative Tangible Equity% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Siemens Healthineers AG (LTS:0PMJ) Overvalued in 2026?
Based on GuruFocus' analysis, Siemens Healthineers AG stock appears to be undervalued.
The current stock price of €34.31 is trading 34.4% below its estimated GF Value™ of €52.27.
GuruFocus considers Siemens Healthineers AG to be Possible Value Trap.
No single metric tells the full story. See the LTS:0PMJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
79GF Score
Get the complete analysis for LTS:0PMJ
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0PMJ has been successfully added to your 
